[Pharmacological and clinical considerations on the association ATP-cardiac glycosides (lanatoside C, strophanthin) in the treatment of arteriosclerotic heart disease]. | CureHunter

HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

[Pharmacological and clinical considerations on the association ATP-cardiac glycosides (lanatoside C, strophanthin) in the treatment of arteriosclerotic heart disease].

Authors	G D DE CAROLIS
Journal	Atti della Societa italiana di cardiologia (Atti Soc Ital Cardiol) Vol. 21(2) Pg. Comunicazioni 115-7 ( 1959) ISSN: 0081-069X [Print] Italy
PMID	13814704 (Publication Type: Journal Article)
Chemical References	Cardiac Glycosides Digitalis Glycosides Lanatosides Strophanthins lanatoside C Adenosine Triphosphate
Topics	Adenosine Triphosphate Cardiac Glycosides Coronary Artery Disease Coronary Disease (therapy) Digitalis (therapy) Digitalis Glycosides Lanatosides Strophanthins (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!